본문 바로가기
KERD
논문KCI 등재

Relapsed extranodal NK/T-cell lymphoma in the mandible, Nasal Type: a case report and review of the literatures

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류치의학

초록

Extranodal NK/T-cell lymphoma (NTCL), nasal type is rare and highly fatal malignant neoplasm. Early diagnosis and establishing treatment plan are very difficult. Furthermore, NTCL in the mandible is an extremely rare condition. The clinical significance of presented case is the very rare location of NTCL. To the best of author’s knowledge, this is the first reported case of NTCL of the mandible in the literature.

Abstract

Extranodal NK/T-cell lymphoma (NTCL), nasal type is rare and highly fatal malignant neoplasm. Early diagnosis and establishing treatment plan are very difficult. Furthermore, NTCL in the mandible is an extremely rare condition. The clinical significance of presented case is the very rare location of NTCL. To the best of author’s knowledge, this is the first reported case of NTCL of the mandible in the literature.

참고문헌 (19)

  1. Lee J, "Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study", JOURNAL OF CLINICAL ONCOLOGY, 24, pp.612~618 (2006), AMER SOC CLINICAL ONCOLOGY
  2. Nakamura S, "Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract", Am J Surg Pathol, 19, pp.284~296 (1995)
  3. Jaffe ES, "Lymphomatoid granulomatosis and angiocentric lymphoma: a spectrum of post-thymic T-cell proliferations", Semin Respir Med, 10, pp.167~172 (1989)
  4. Mroczek EC, "Fatal infectious mononucleosis and virus-associated hemo phagocytic syndrome", Arch Pathol Lab Med, 111, pp.530~535 (1987)
  5. Pileri SA, "Malignant lymphoma involving the mandible. Clinical, morphologic, and immunohistochemical study of 17 cases", Am J Surg Pathol, 14, pp.652~659 (1990)
  6. Mafune KI, "Outcome of patients with non-Hodgkin’s lymphoma of the stomach after gastrectomy: clinicopathologic study and reclassification according to the revised European-American lymphoma classification", Gastric Cancer, 4, pp.137~143 (2001)
  7. Harris NL, "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood, 84, pp.1361~1392 (1994)
  8. Chorianopoulos D, "Extranodal natural killer", Tcell lymphoma, 2010, pp.8, 56~58
  9. Kwong YL, "Natural killer-cell malignancies: diagnosis and treatment", Leukemia, 19, pp.2186~2194 (2005)
  10. Oshimi K, "Progress in understanding and managing natural killer-cell malignancies", Br J Haematol, 139, pp.532~544 (2007)
  11. Au WY, "Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients", Blood, 104, pp.243~249 (2004)
  12. Au WY, "Clinical differences between nasal and extranasal natural killer", T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project, 2009, pp.113, 3931~3937
  13. Wong KF, "CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous", mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity, 1992, pp.23, 798~804
  14. Sakata K, "Treatment of lethal midline granuloma type nasal T-cell lymphoma", Acta Oncol, 36, pp.307~311 (1997)
  15. Kim GE, "Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck", Radiother Oncol, 61, pp.261~269 (2001)
  16. Kim GE, "Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment", J Clin Oncol, 18, pp.54~63 (2000)
  17. Lee KW, "First-line ifosfamide, methotrexate, etoposide, and prednisolone chemotherapy +", - radiotherapy in active stage I, T-cell lymphoma, pp.Leuk Lymphoma, 2006[DOI]
  18. Yamaguchi M, "Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)", T-cell lymphoma and leukemia, 2008, pp.99, 1016~1020
  19. Kim BS, "Effective second-line chemotherapy for extranodal NK", T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone, 2009, pp.20, 121~128

관련 논문AI추천

이 간행물의 다른 논문 (9건)